Cytori to Webcast Third Quarter Financial Results on November 8
SAN DIEGO -- November 01, 2012
Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third
quarter financial results and business update on Thursday, November 8, 2012 at
5:00 PM Eastern Time.
The dial-in information is as follows:
Dial-In Number: +1.877.402.3914
Conference ID: 42763342
Prior to the webcast at approximately 4:05 PM Eastern Time on November 8,
Cytori will issue its third quarter earnings release and post a quarterly
shareholder letter to its Investor Relations homepage, which will review
Cytori's third quarter performance.
The webcast will be available both live and by replay two hours after the call
under “Webcasts” on the Company's Investor Relations website
Cytori Therapeutics is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow. As a result, we believe these cells can be applied across multiple
“ischemic” conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori’s proprietary technologies and
products, including the Celution® System product family. www.cytori.com
Press spacebar to pause and continue. Press esc to stop.